Cargando…

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies

Detalles Bibliográficos
Autores principales:	Pereira-Barretto, AC, Rassi, S, Vilas-Boas, F, Ribeiro, JP, Albuquerque, DC, Lage, SG, Baima, J, Bocchi, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301021/ http://dx.doi.org/10.1186/cc2219

Ejemplares similares

Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry
por: Perrone, SV, et al.
Publicado: (2003)

Clinical findings and prognosis of patients hospitalized for acute decompensated heart failure: Analysis of the influence of Chagas etiology and ventricular function
por: Terhoch, Caíque Bueno, et al.
Publicado: (2018)

The course of patients with Chagas heart disease during episodes of decompensated heart failure
por: Issa, Victor Sarli, et al.
Publicado: (2021)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
por: Sandell, E-P, et al.
Publicado: (2002)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
por: Lilleberg, J, et al.
Publicado: (2002)

Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
por: Bocchi, Edimar Alcides, et al.
Publicado: (2018)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Myocardial efficiency during levosimendan infusion
por: Voipio-Pulkki, L-M, et al.
Publicado: (2002)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure
por: Korkmaz, Hasan, et al.
Publicado: (2019)

Levosimendan preconditioning in patients undergoing elective cardiac surgery with poor ejection fraction. preliminary results.
por: Ávalos, R, et al.
Publicado: (2015)

Hemodynamic effects of levosimendan after surgery in LPS pretreated rabbits
por: Faivre, V, et al.
Publicado: (2003)

Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial
por: Bocchi, Edimar Alcides, et al.
Publicado: (2017)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Mode of Death on Chagas Heart Disease: Comparison with Other Etiologies. A Subanalysis of the REMADHE Prospective Trial
por: Ayub-Ferreira, Silvia M., et al.
Publicado: (2013)

Interaction between renal function and the effect of levosimendan on long-term mortality of patients with low-output heart failure
por: Cleland, J, et al.
Publicado: (2003)

Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure
por: Suominen, Pertti K
Publicado: (2011)

Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016)

Effect of Levosimendan on Acute Decompensated Right Heart Failure in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Qu, Chao, et al.
Publicado: (2022)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Dobutamine Stress Echocardiography Safety in Chagas Disease Patients
por: Rassi, Daniela do Carmo, et al.
Publicado: (2017)

Effect of β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output heart failure
por: Follath, F, et al.
Publicado: (2002)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Chagas’ disease: the hidden enemy around the world
por: Bocchi, Edimar Alcides
Publicado: (2022)

Evaluation of the understanding the degree of diabetes decompensation in elderly patients without satisfactory glycemic control
por: Machry, Rafael Vaz, et al.
Publicado: (2015)

The effects of levosimendan on myocardial oxygen consumption and coronary blood flow early after coronary artery bypass grafting
por: Lilleberg, J, et al.
Publicado: (2002)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2003)

Prognosis and risk stratification in patients with decompensated heart failure receiving inotropic therapy
por: Gomes, Clara, et al.
Publicado: (2018)

Reproducibility of point-of-care cardiac ultrasound in Chagas disease by a non-cardiologist with limited training
por: Kreuser, Lucas Jordan, et al.
Publicado: (2014)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

Clinical Characteristics, Etiology, and Prognostic Scores in Patients with Acute Decompensated Liver Cirrhosis
por: Al Kaabi, Hoor, et al.
Publicado: (2023)

Cytokines and sepsis
por: Marum, S, et al.
Publicado: (1999)

Infection in Patients with Decompensated Heart Failure: In-Hospital Mortality and Outcome
por: Cardoso, Juliano Novaes, et al.
Publicado: (2018)

Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis
por: Cai, Qun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mhnifsjcapthamrg4aa9c6vck2